TY - JOUR
T1 - Association between Baseline Osteoarthritic Features on MR Imaging and Clinical Outcome after Genicular Artery Embolization for Knee Osteoarthritis
AU - van Zadelhoff, Tijmen A.
AU - Okuno, Yuji
AU - Bos, Pieter K.
AU - Bierma-Zeinstra, Sita M.A.
AU - Krestin, Gabriel P.
AU - Moelker, Adriaan
AU - Oei, Edwin H.G.
N1 - Publisher Copyright: © 2020 SIR
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Purpose: To explore the association between baseline osteoarthritis (OA)-related magnetic resonance (MR) imaging features and pain reduction after genicular artery embolization (GAE) in patients with mild-to-moderate symptomatic knee OA resistant to conservative therapy. Materials and Methods: This was a retrospective analysis of patients with mild-to-moderate symptomatic knee OA treated with GAE using imipenem-cilastatin sodium. The clinical outcome was scored at baseline and 6 months after treatment using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). MR images were scored using the MR imaging osteoarthritis knee score. Linear regression was used to evaluate associations of before-treatment MR imaging scores with WOMACpain and WOMACtotal reduction after 6 months. Results: Fifty-four patients (22.2% male; median age, 69.4 years; median WOMACpain at baseline, 12) were evaluated. Of all OA features scored, a higher cartilage full-thickness defect score showed the strongest association with less reduction of both WOMACpain (B,−0.63 [95% confidence interval (CI), −0.91 to −0.34]; P <.001) and WOMACtotal scores (B, −1.77 [95% CI, −2.87 to −0.67]; P <.001) following treatment. The presence of grade 2–3 effusion synovitis (B, −2.99 [95% CI, −5.39 to −0.60]) bone marrow lesions (B, −0.52 [95% CI, −0.86 to −0.19]), osteophytes (B, −0.21 [95% CI, −0.36 to −0.06]), and cartilage defect surface area score (B, −0.25 [95% CI −0.42 to −0.08]) all showed a significant association with less WOMACpain reduction (all P <.05). Conclusions: In patients with mild-to-moderate symptomatic knee OA treated with GAE, the presence and severity of full-thickness cartilage defects, effusion synovitis, bone marrow lesions, osteophytes, and cartilage surface area scores at baseline are associated with less favorable clinical outcomes at 6 months.
AB - Purpose: To explore the association between baseline osteoarthritis (OA)-related magnetic resonance (MR) imaging features and pain reduction after genicular artery embolization (GAE) in patients with mild-to-moderate symptomatic knee OA resistant to conservative therapy. Materials and Methods: This was a retrospective analysis of patients with mild-to-moderate symptomatic knee OA treated with GAE using imipenem-cilastatin sodium. The clinical outcome was scored at baseline and 6 months after treatment using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). MR images were scored using the MR imaging osteoarthritis knee score. Linear regression was used to evaluate associations of before-treatment MR imaging scores with WOMACpain and WOMACtotal reduction after 6 months. Results: Fifty-four patients (22.2% male; median age, 69.4 years; median WOMACpain at baseline, 12) were evaluated. Of all OA features scored, a higher cartilage full-thickness defect score showed the strongest association with less reduction of both WOMACpain (B,−0.63 [95% confidence interval (CI), −0.91 to −0.34]; P <.001) and WOMACtotal scores (B, −1.77 [95% CI, −2.87 to −0.67]; P <.001) following treatment. The presence of grade 2–3 effusion synovitis (B, −2.99 [95% CI, −5.39 to −0.60]) bone marrow lesions (B, −0.52 [95% CI, −0.86 to −0.19]), osteophytes (B, −0.21 [95% CI, −0.36 to −0.06]), and cartilage defect surface area score (B, −0.25 [95% CI −0.42 to −0.08]) all showed a significant association with less WOMACpain reduction (all P <.05). Conclusions: In patients with mild-to-moderate symptomatic knee OA treated with GAE, the presence and severity of full-thickness cartilage defects, effusion synovitis, bone marrow lesions, osteophytes, and cartilage surface area scores at baseline are associated with less favorable clinical outcomes at 6 months.
UR - http://www.scopus.com/inward/record.url?scp=85100074085&partnerID=8YFLogxK
U2 - 10.1016/j.jvir.2020.12.008
DO - 10.1016/j.jvir.2020.12.008
M3 - Article
C2 - 33526342
AN - SCOPUS:85100074085
SN - 1051-0443
VL - 32
SP - 497
EP - 503
JO - Journal of Vascular and Interventional Radiology
JF - Journal of Vascular and Interventional Radiology
IS - 4
ER -